← Leaderboards
Ping Cao
Targead Sciences, Inc.
$521,928
Attributed
$521,928
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $298.9K · FY2018–20$500K$375K$250K$125K$0
'18
'19
'20
Funding mix
By agency
NIH$521,928 · 2
By mechanism
R41$298,928 · 1
R43$223,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Small Molecule”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- John Damon Chodera · Sloan-Kettering Inst Can Research$32,426,535
- Xinhua Li · Nano Terra, Inc.$29,432,783
- Leonard Freedman · Leidos Biomedical Research, Inc.$14,890,784
- Alan Johnson · Hawaii Biotech, Inc.$14,045,226
Research focus
Small MoleculeCancer CellMutantResistanceCell LineBaseGenesLifeOncogenicPropertyTargeted TreatmentValidationPharmacologyPharmaceutical PreparationsCell ProliferationCellsIn VivoLeadBioluminescenceBiological SciencesAminesBiochemicalBindingAlkynes
Grant awards (3)
Development of an irreversible covalent inhibitor of FMS-like tyrosine kinase receptor 3 for treating acute myeloid leukemia$298,928
R41 · FY2020 · CA · contact PI
A Novel Chemical Proteomics Platform to Expand Druggable Space$168,331
R43 · FY2018 · GM · contact PI
A Novel Chemical Proteomics Platform to Expand Druggable Space$54,669
R43 · FY2018 · GM · contact PI